{
    "Trade/Device Name(s)": [
        "Plexus EBV IgM Multi-Analyte Diagnostics"
    ],
    "Submitter Information": "Focus Diagnostics, Inc.",
    "510(k) Number": "K073381",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992306",
        "K974013",
        "K993252",
        "K961504"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LJN"
    ],
    "Summary Letter Date": "November 30, 2007",
    "Summary Letter Received Date": "December 3, 2007",
    "Submission Date": "November 30, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.3235"
    ],
    "Regulation Name(s)": [
        "Epstein-Barr Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "serology"
    ],
    "Analyte(s)": [
        "Epstein-Barr Virus viral capsid antigen IgM antibodies",
        "Heterophile antibodies"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Luminex XMAP technology",
        "Plexus software"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex Microbead Immunoassay (MMIA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Microbead technology"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Plexus EBV IgM Multi-Analyte Diagnostics qualitative immunoassay for EBV VCA IgM and heterophile antibodies in human serum using Luminex XMAP platform.",
    "Indications for Use Summary": "Intended for qualitative detection of human IgM antibodies to EBV viral capsid antigen (VCA) and heterophile antibodies in serum as an aid in diagnosis of EBV infection and EBV-associated infectious mononucleosis.",
    "fda_folder": "Microbiology"
}